These are mechanically computed values based on a residual income model. They are not a forecast of market prices or a recommendation of any investment action, and do not predict or guarantee future share prices. Historical values are computed retrospectively using current guidance-achievement statistics.
| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥6768.5B | ¥6420.5B | +5.4% |
| Operating Income | ¥733.1B | ¥326.1B | +124.8% |
| Profit Before Tax | ¥727.5B | ¥304.1B | +139.2% |
| Net Income | ¥490.4B | ¥199.2B | +146.2% |
| ROE | 6.1% | 2.7% | - |
The cumulative Q2 period resulted in significant increases in both revenue and earnings, primarily due to recovering demand and improved profitability in the Semiconductor and Electronic Materials Business. Revenue was ¥6,768.5B (+5.4% YoY), Operating Income was ¥733.1B (+124.8%), Profit Before Tax was ¥727.5B (+139.2%; as the company adopts IFRS, there is no concept corresponding to Ordinary Income), and consolidated Net Income was ¥490.4B (+146.2%). The Operating Income Margin improved significantly to 10.8% from 5.1% in the same period of the previous year, mainly due to the improvement in the gross profit margin to 30.5% from 23.6%. Progress against the full-year earnings forecast was 58.1% for Revenue, compared with 45.8% for Operating Income and 43.1% for Net Income attributable to owners of the parent, indicating somewhat slower earnings progress and a plan weighted toward the second half.
【Revenue】Revenue was ¥6,768.5B, an increase of +5.4% YoY. Semiconductor and Electronic Materials, the largest segment, posted Revenue of ¥2,989.6B (44.2% of total Revenue), a substantial increase of +29.6%, driving company-wide performance. In contrast, Crasus Chemical recorded ¥1,300.6B (19.2% of total Revenue), down 13.2%, while Mobility recorded ¥846.2B (12.5%), down 5.6%. Chemicals recorded ¥917.9B (13.6%), up +17.0%, and Innovation Enabling Materials recorded ¥500.0B (7.4%), up +11.3%. The primary drivers of Revenue growth were recovering demand and improved pricing and product mix in Semiconductor and Electronic Materials.
【Profit and Loss】Operating Income was ¥733.1B, a substantial increase of +124.8% YoY. The gross profit margin improved by +6.9pt to 30.5% from 23.6%, while the SG&A ratio declined to 17.5% from 18.2%, resulting in operating leverage. By segment, Semiconductor and Electronic Materials was the core contributor to company-wide earnings, with Operating Income of ¥814.9B (27.3% margin). Chemicals remained loss-making at -¥6.1B, but the loss narrowed substantially from -¥81.6B in the previous year, while Mobility generated ¥42.8B (5.1% margin). Total segment Operating Income was ¥985.6B, and the difference of approximately ¥252.5B from consolidated Operating Income of ¥733.1B was attributable to unallocated items, including corporate expenses. Profit Before Tax was ¥727.5B (+139.2%), and consolidated Net Income was ¥490.4B (+146.2%). The effective tax rate declined to 32.6% from 34.5%, contributing to the earnings increase. Overall, the results reflected growth in both Revenue and earnings.
Semiconductor and Electronic Materials was the largest segment, accounting for 44.2% of total Revenue (35.9% in the previous year), and was the core of company-wide earnings, with Operating Income of ¥814.9B (+91.8% YoY; 27.3% margin). Crasus Chemical achieved a substantial increase in Operating Income to ¥38.4B (+576.2%) despite Revenue of ¥1,300.6B (-13.2%), improving its margin to 3.0%. Chemicals recorded Revenue of ¥917.9B (+17.0%) and Operating Income of -¥6.1B, representing a 92.5% improvement from -¥81.6B in the previous year. Although the segment remains loss-making, the loss is narrowing. Mobility recorded Revenue of ¥846.2B (-5.6%) and Operating Income of ¥42.8B (+227.4%; 5.1% margin), securing higher earnings despite lower Revenue. Innovation Enabling Materials showed stable growth, with Revenue of ¥500.0B (+11.3%) and Operating Income of ¥63.0B (+27.5%; 12.6% margin). Other segments recorded Revenue of ¥214.2B (-55.8%) and Operating Income of ¥32.7B (+52.2%; 15.2% margin). The disparity in margins between segments is significant—27.3% for Semiconductor and Electronic Materials versus -0.7% for Chemicals—and company-wide earnings remain highly dependent on Semiconductor and Electronic Materials.
【Profitability】The Operating Income Margin improved by +5.7pt to 10.8% from 5.1% in the same period of the previous year, while the Net Profit Margin increased by +4.1pt to 7.2% (based on consolidated Net Income of ¥490.4B) from 3.1%. The gross profit margin improved to 30.5% from 23.6%, serving as the primary driver of improved profitability.【Cash Flow Quality】Operating Cash Flow (OCF) was ¥844.0B, equivalent to 1.72 times consolidated Net Income of ¥490.4B, indicating strong cash backing for earnings. Free cash flow was positive at ¥274.1B, exceeding dividend payments of ¥117.3B.【Investment Efficiency】ROE was 6.1% (based on Net Income attributable to owners of the parent and equity at period-end), while ROA based on total assets was approximately 2.2%. Total asset turnover remained low at approximately 0.31x, suggesting room for improvement in asset efficiency.【Financial Soundness】The Equity Ratio rose by +2.4pt to 35.6% from 33.2% in the same period of the previous year. Against total interest-bearing debt of ¥9,348.6B, the company held ¥3,270.7B in cash and cash equivalents. Interest coverage (Operating Income/finance costs) was approximately 9.6x, indicating strong debt-servicing capacity.
Operating Cash Flow increased substantially by +143.7% YoY to ¥844.0B, reflecting higher earnings. In terms of working capital, an increase in inventories was a cash outflow factor of ¥386.8B, while trade receivables also represented an increase factor of ¥165.9B. Trade payables increased by ¥228.0B, partially offsetting these effects. Investing Cash Flow was -¥569.9B, of which capital expenditures accounted for ¥524.2B, indicating continued investment in growth areas. Financing Cash Flow was positive at +¥94.8B, including dividend payments of ¥117.3B. Resulting Free Cash Flow was positive at ¥274.1B, or 2.3 times dividend payments, indicating that cash generation during the period was sufficient to fund investment and shareholder returns. Cash and cash equivalents accumulated to ¥3,270.7B at period-end.
One-time factors during the period were limited to impairment losses of ¥8.2B (¥1.4B in the previous year), and the majority of Operating Income of ¥733.1B was generated by recurring business activities. Non-operating expenses exceeded non-operating income: finance income was ¥24.3B versus finance costs of ¥76.4B, while other income was ¥44.0B versus other expenses of ¥190.2B. However, their scale relative to Operating Income was limited. Equity-method investment gain was ¥46.5B, contributing only 6.4% of Profit Before Tax of ¥727.5B, indicating that recovery in core business earnings was the primary driver. Comprehensive Income was ¥648.3B (¥643.2B attributable to owners of the parent), a +¥157.9B difference from consolidated Net Income of ¥490.4B, primarily due to foreign currency translation adjustments of +¥148.3B. Translation gains on overseas assets resulting from yen depreciation lifted Comprehensive Income and should be evaluated separately from earnings power based on Net Income. OCF was 1.72 times consolidated Net Income, indicating a small divergence between accrual-based and cash-based earnings and supporting a favorable assessment of earnings quality.
Progress against the full-year earnings forecast was 58.1% for Revenue (¥6,768.5B/¥11,650.0B), 45.8% for Operating Income (¥733.1B/¥1,600.0B), and 43.1% for Net Income attributable to owners of the parent (¥484.5B/¥1,125.0B). While Revenue is progressing somewhat ahead of schedule against the full-year plan, earnings progress is below the standard 50% benchmark, indicating a plan weighted toward the second half. During Q2, the earnings forecast was revised, with full-year Operating Income planned to increase substantially by +278.5% YoY and Net Income by +287.5%. There was no revision to the dividend forecast, which remains an annual dividend of ¥65.
The dividend forecast is an annual ¥65 (interim dividend of ¥0 and planned year-end dividend of ¥65), with no revision during the quarter. Based on the number of shares calculated by deducting treasury shares from shares outstanding at period-end, total annual dividends are approximately ¥123B, resulting in a Payout Ratio of approximately 11.0% against the full-year Net Income forecast of ¥1,125B (attributable to owners of the parent). First-half Free Cash Flow of ¥274.1B was 2.3 times first-half dividend payments of ¥117.3B, confirming sufficient cash generation to support dividends. Share repurchases were limited to ¥0.2B in the first half, and shareholder returns currently center on dividends.
Concentration of earnings in Semiconductor and Electronic Materials: Operating Income of ¥814.9B from this segment is equivalent to 111.2% of consolidated Operating Income of ¥733.1B, meaning that market fluctuations have a significant impact on company-wide performance. Its share of total Revenue also rose to 44.2% from 35.9% in the previous year, indicating increasing dependence.
Inventory accumulation and working capital burden: Inventories were ¥2,457.9B, an increase of +¥397.3B (+19.3%) YoY, accumulating at a pace exceeding Revenue growth of +5.4%. On the statement of cash flows, the increase in inventories was also a cash outflow factor of ¥386.8B, requiring monitoring of inventory efficiency.
Profitability of the Chemicals segment: The Chemicals segment remained loss-making, with Operating Income of -¥6.1B against Revenue of ¥917.9B (+17.0%), although this improved from -¥81.6B in the previous year. The profitability gap remains, with the segment margin at -0.7% versus the company-wide margin of 10.8%.
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 10.8% | 9.7% (5.4%–23.7%) | +1.2pt |
| Net Profit Margin | 7.2% | 5.4% (1.3%–20.1%) | +1.8pt |
Both the Operating Income Margin and Net Profit Margin exceed the industry median, indicating that profitability is relatively high within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 5.4% | 10.6% (-3.4%–25.4%) | -5.2pt |
Revenue growth is below the industry median, indicating a relatively modest pace of Revenue growth within the industry.
※Source: Compiled by the Company
The gross profit margin improved by +6.9pt YoY (23.6%→30.5%), while the Operating Income Margin improved by +5.7pt (5.1%→10.8%). Improved profitability in Semiconductor and Electronic Materials is raising the company-wide earnings structure. Future quarterly trends will help determine whether this improvement is a temporary pricing effect or a structural change in product mix.
OCF was 1.72 times consolidated Net Income and FCF was positive at ¥274.1B, indicating favorable cash conversion. However, inventories increased by +19.3% YoY, exceeding Revenue growth, which warrants attention from a working capital efficiency perspective.
Full-year progress was 58.1% for Revenue, while earnings progress remained at 45.8% for Operating Income and 43.1% for Net Income. Semiconductor demand and pricing trends in the second half, as well as the continuation of profitability improvements in the Chemicals segment, will be key areas of focus for achieving the plan.
This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type model with an explicit 5-year fade). It is not a forecast of the market share price or a recommendation of any specific investment action.
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥4,806 |
| base | ¥4,995 |
| bull | ¥5,149 |
| Calculation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥4,157 |
| Adjusted Forecast EPS | ¥651.7 |
| Cost of Equity r | 9.27% (10-year government bond 2.77% + equity risk premium 6.00% + size premium 0.50%) |
| Residual Income Persistence Coefficient ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 10.7% |
| Forecast EPS Confidence Adjustment | ×1.075 (based on the peer-industry track record of achieving guidance) |
| Implied PBR / PER |
Sensitivity: ¥4,848–¥5,148 at Cost of Equity ±1%, and ¥4,973–¥5,028 at ω±0.1.
Notes:
(Calculation model: Residual Income Model / Interest rate reference month: 2026-07 / This value does not forecast or guarantee the future share price)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, and you should consult a professional as necessary.
---End of Report---
| 1.20x / 7.7x |